Functional Differences between Mitochondrial Haplogroup T and Haplogroup H in HEK293 Cybrid Cells

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Mueller, Edith E ^a   Brunner, Susanne M ^a   Mayr, Johannes A ^a   Stanger, Olaf ^a,b   Sperl, Wolfgang ^a   Kofler, Barbara ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL FUNCTION; CELL FUSION; CELL ISOLATION; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DOSAGE; GENETIC SUSCEPTIBILITY; GROWTH RATE; HAPLOTYPE; HUMAN; HUMAN CELL; MITOCHONDRIAL GENOME; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; SURVIVAL RATE; THROMBOCYTE;

CELL PROLIFERATION; DNA, MITOCHONDRIAL; GENE DOSAGE; HAPLOTYPES; HEK293 CELLS; HUMANS; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS;

EID: 84871554974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052367     Document Type: Article

References (60)

1. Ballard JW, Whitlock MC, (2004) The incomplete natural history of mitochondria. Mol Ecol 13: 729-744.
2. Wallace DC, (1999) Mitochondrial diseases in man and mouse. Science 283: 1482-1488.
3. Taylor RW, Turnbull DM, (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6: 389-402.
4. Wallace DC, (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39: 359-407.
5. Tranah GJ, Manini TM, Lohman KK, Nalls MA, Kritchevsky S, et al. (2011) Mitochondrial DNA variation in human metabolic rate and energy expenditure. Mitochondrion 11: 855-861.
6. Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN, (2007) Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett 249: 249-255.
7. van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, et al. (2004) Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365: 28-32.
8. Ruiz-Pesini E, Lapena AC, Diez-Sanchez C, Perez-Martos A, Montoya J, et al. (2000) Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am J Hum Genet 67: 682-696.
9. Castro MG, Huerta C, Reguero JR, Soto MI, Domenech E, et al. (2006) Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy. Int J Cardiol 112: 202-206.
10. Hulgan T, Haas DW, Haines JL, Ritchie MD, Robbins GK, et al. (2005) Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. Aids 19: 1341-1349.
11. Mueller EE, Schaier E, Brunner SM, Eder W, Mayr JA, et al. (2012) Mitochondrial haplogroups and control region polymorphisms in age-related macular degeneration: a case-control study. PLoS ONE 7: e30874.
12. Kofler B, Mueller EE, Eder W, Stanger O, Maier R, et al. (2009) Mitochondrial DNA haplogroup T is associated with coronary artery disease and diabetic retinopathy: a case control study. BMC Med Genet 10: 35.
13. Canter JA, Olson LM, Spencer K, Schnetz-Boutaud N, Anderson B, et al. (2008) Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration. PLoS One 3: e2091.
14. SanGiovanni JP, Arking DE, Iyengar SK, Elashoff M, Clemons TE, et al. (2009) Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS One 4: e5508.
15. Crispim D, Canani LH, Gross JL, Tschiedel B, Souto KE, et al. (2006) The European-specific mitochondrial cluster J/T could confer an increased risk of insulin-resistance and type 2 diabetes: an analysis of the m.4216T>C and m.4917A>G variants. Ann Hum Genet 70: 488-495.
16. Castro MG, Terrados N, Reguero JR, Alvarez V, Coto E, (2007) Mitochondrial haplogroup T is negatively associated with the status of elite endurance athlete. Mitochondrion 7: 354-357.
17. Baudouin SV, Saunders D, Tiangyou W, Elson JL, Poynter J, et al. (2005) Mitochondrial DNA and survival after sepsis: a prospective study. Lancet 366: 2118-2121.
18. Jones MM, Manwaring N, Wang JJ, Rochtchina E, Mitchell P, et al. (2007) Mitochondrial DNA haplogroups and age-related maculopathy. Arch Ophthalmol 125: 1235-1240.
19. Chagnon P, Gee M, Filion M, Robitaille Y, Belouchi M, et al. (1999) Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am J Med Genet 85: 20-30.
20. Fesahat F, Houshmand M, Panahi MS, Gharagozli K, Mirzajani F, (2007) Do haplogroups H and U act to increase the penetrance of Alzheimer's disease? Cell Mol Neurobiol 27: 329-334.
21. Maruszak A, Canter JA, Styczynska M, Zekanowski C, Barcikowska M, (2009) Mitochondrial haplogroup H and Alzheimer's disease-is there a connection? Neurobiol Aging 30: 1749-1755.
22. Santoro A, Balbi V, Balducci E, Pirazzini C, Rosini F, et al. (2010) Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease. PLoS ONE 5: e12037.
23. Bacman SR, Moraes CT, (2007) Transmitochondrial technology in animal cells. Methods Cell Biol 80: 503-524.
24. Vergani L, Martinuzzi A, Carelli V, Cortelli P, Montagna P, et al. (1995) MtDNA mutations associated with Leber's hereditary optic neuropathy: studies on cytoplasmic hybrid (cybrid) cells. Biochem Biophys Res Commun 210: 880-888.
25. Vives-Bauza C, Gonzalo R, Manfredi G, Garcia-Arumi E, Andreu AL, (2006) Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA. Neurosci Lett 391: 136-141.
26. Kazuno AA, Munakata K, Nagai T, Shimozono S, Tanaka M, et al. (2006) Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet 2: e128.
27. Gomez-Duran A, Pacheu-Grau D, Lopez-Gallardo E, Diez-Sanchez C, Montoya J, et al. (2010) Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 19: 3343-3353.
28. Bellizzi D, Cavalcante P, Taverna D, Rose G, Passarino G, et al. (2006) Gene expression of cytokines and cytokine receptors is modulated by the common variability of the mitochondrial DNA in cybrid cell lines. Genes Cells 11: 883-891.
29. Bellizzi D, Taverna D, D'Aquila P, De Blasi S, De Benedictis G, (2009) Mitochondrial DNA variability modulates mRNA and intra-mitochondrial protein levels of HSP60 and HSP75: experimental evidence from cybrid lines. Cell Stress Chaperones 14: 265-271.
30. Pello R, Martin MA, Carelli V, Nijtmans LG, Achilli A, et al. (2008) Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum Mol Genet 17: 4001-4011.
31. Mueller EE, Mayr JA, Zimmermann FA, Feichtinger RG, Stanger O, et al. (2012) Reduction of nuclear encoded enzymes of mitochondrial energy metabolism in cells devoid of mitochondrial DNA. Biochem Biophys Res Commun 417: 1052-1057.
32. van Oven M, Kayser M (2009) Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat 30: E386-E394. http://www.phylotree.org. Accessed 2012 November 19.
33. Ingman M, Gyllensten U (2006) mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic Acids Res 34: D749-751. Accessed 2012 November 19.
34. Aquadro CF, Greenberg BD, (1983) Human mitochondrial DNA variation and evolution: analysis of nucleotide sequences from seven individuals. Genetics 103: 287-312.
35. Greenberg BD, Newbold JE, Sugino A, (1983) Intraspecific nucleotide sequence variability surrounding the origin of replication in human mitochondrial DNA. Gene 21: 33-49.
36. Horai S, Hayasaka K, (1990) Intraspecific nucleotide sequence differences in the major noncoding region of human mitochondrial DNA. Am J Hum Genet 46: 828-842.
37. Stoneking M, Hedgecock D, Higuchi RG, Vigilant L, Erlich HA, (1991) Population variation of human mtDNA control region sequences detected by enzymatic amplification and sequence-specific oligonucleotide probes. Am J Hum Genet 48: 370-382.
38. Hofmann S, Jaksch M, Bezold R, Mertens S, Aholt S, et al. (1997) Population genetics and disease susceptibility: characterization of central European haplogroups by mtDNA gene mutations, correlation with D loop variants and association with disease. Hum Mol Genet 6: 1835-1846.
39. Stenico M, Nigro L, Bertorelle G, Calafell F, Capitanio M, et al. (1996) High mitochondrial sequence diversity in linguistic isolates of the Alps. Am J Hum Genet 59: 1363-1375.
40. Kivisild T, Bamshad MJ, Kaldma K, Metspalu M, Metspalu E, et al. (1999) Deep common ancestry of indian and western-Eurasian mitochondrial DNA lineages. Curr Biol 9: 1331-1334.
41. Brandstatter A, Sanger T, Lutz-Bonengel S, Parson W, Beraud-Colomb E, et al. (2005) Phantom mutation hotspots in human mitochondrial DNA. Electrophoresis 26: 3414-3429.
42. Malyarchuk BA, Derenko MV, (1999) Molecular instability of the mitochondrial haplogroup T sequences at nucleotide positions 16292 and 16296. Ann Hum Genet 63: 489-497.
43. MITOMAP: A Human Mitochondrial Genome Database. http://www.mitomap.org, 2011. Accessed 2012 Nov 19.
44. Sternberg D, Danan C, Lombes A, Laforet P, Girodon E, et al. (1998) Exhaustive scanning approach to screen all the mitochondrial tRNA genes for mutations and its application to the investigation of 35 independent patients with mitochondrial disorders. Hum Mol Genet 7: 33-42.
45. Ebenesersdottir SS, Sigurethsson A, Sanchez-Quinto F, Lalueza-Fox C, Stefansson K, et al. (2011) A new subclade of mtDNA haplogroup C1 found in Icelanders: evidence of pre-Columbian contact? Am J Phys Anthropol 144: 92-99.
46. Wojtczak L, (1996) The Crabtree effect: a new look at the old problem. Acta Biochim Pol 43: 361-368.
47. Carelli V, Vergani L, Bernazzi B, Zampieron C, Bucchi L, et al. (2002) Respiratory function in cybrid cell lines carrying European mtDNA haplogroups: implications for Leber's hereditary optic neuropathy. Biochim Biophys Acta 1588: 7-14.
48. Amo T, Yadava N, Oh R, Nicholls DG, Brand MD, (2008) Experimental assessment of bioenergetic differences caused by the common European mitochondrial DNA haplogroups H and T. Gene. 411: 69-76.
49. Warburg O, (1956) On the origin of cancer cells. Science 123: 309-314.
50. Moreno-Loshuertos R, Acin-Perez R, Fernandez-Silva P, Movilla N, Perez-Martos A, et al. (2006) Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet 38: 1261-1268.
51. Martinez-Redondo D, Marcuello A, Casajus JA, Ara I, Dahmani Y, et al. (2010) Human mitochondrial haplogroup H: the highest VO2max consumer-is it a paradox? Mitochondrion 10: 102-107.
52. Arning L, Haghikia A, Taherzadeh-Fard E, Saft C, Andrich J, et al. (2010) Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. J Mol Med (Berl) 88: 431-436.
53. Mayr JA, Merkel O, Kohlwein SD, Gebhardt BR, Bohles H, et al. (2007) Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation. Am J Hum Genet 80: 478-484.
54. Meierhofer D, Mayr JA, Ebner S, Sperl W, Kofler B, (2005) Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations. Mitochondrion 5: 282-296.
55. Bentlage HA, Wendel U, Schagger H, ter Laak HJ, Janssen AJ, et al. (1996) Lethal infantile mitochondrial disease with isolated complex I deficiency in fibroblasts but with combined complex I and IV deficiencies in muscle. Neurology 47: 243-248.
56. Berger A, Mayr JA, Meierhofer D, Fotschl U, Bittner R, et al. (2003) Severe depletion of mitochondrial DNA in spinal muscular atrophy. Acta Neuropathol 105: 245-251.
57. Feichtinger RG, Zimmermann F, Mayr JA, Neureiter D, Hauser-Kronberger C, et al. (2010) Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma. BMC Cancer 10: 149.
58. Babich H, Liebling EJ, Burger RF, Zuckerbraun HL, Schuck AG, (2009) Choice of DMEM, formulated with or without pyruvate, plays an important role in assessing the in vitro cytotoxicity of oxidants and prooxidant nutraceuticals. In Vitro Cell Dev Biol Anim 45: 226-233.
59. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E, (2008) The antioxidant properties of serum albumin. FEBS Lett 582: 1783-1787.
60. O'Brien J, Wilson I, Orton T, Pognan F, (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267: 5421-5426.